NCT05418296

Brief Summary

This Phase 1 study looks at how a new videogame-based program can help residents and care partners prepare for ADLs in a fun way with minimal risk, potentially reducing escalating problems associated with ADL completions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2022

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 31, 2022

Completed
9 days until next milestone

Study Start

First participant enrolled

June 9, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 14, 2022

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2023

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

February 10, 2025

Completed
Last Updated

February 10, 2025

Status Verified

January 1, 2025

Enrollment Period

1.2 years

First QC Date

May 31, 2022

Results QC Date

December 20, 2024

Last Update Submit

January 17, 2025

Conditions

Keywords

technologydementiaAlzheimer's diseasevirtualbehavioralcognitiveimmersivecaregiverdigital healthvideogamememorynon-pharmacological

Outcome Measures

Primary Outcomes (2)

  • Alzheimer's Disease Cooperative Study Activities of Daily Living (ADCS-ADL- Severe)

    The ADCS-ADL assesses the competence of patients with Alzheimer's Disease (AD) in basic and instrumental activities of daily living (ADLs). It can be completed by a caregiver in questionnaire format, or administered by a clinician/researcher as a structured interview with a caregiver. There are 19 questions. The minimum and maximum values are 0 - 54. A higher score means a better outcome.

    6 weeks

  • The Neuropsychiatric Inventory - Nursing Home Version (NPI-NH) The Minimum and Maximum Values Are A Higher Score Means a Better or Worse Outcome.

    The NPI-NH The NPI-NH has been used to characterize the psychopathology of patients in nursing homes as well as to measure the impact of anti dementia and psychotropic drugs and behavioral changes in dementia patients dwelling in nursing homes. There are questions. The minimum and maximum values are 12 - 120 A lower score means a better outcome.

    6 weeks

Secondary Outcomes (3)

  • Approaches to Dementia Questionnaire (ADQ)

    6 weeks

  • Sense of Competence in Dementia Care Staff (SCIDS) Scale

    6 weeks

  • The Copenhagen Burnout Index

    6 weeks

Study Arms (1)

Persons residing in long-term care homes

EXPERIMENTAL

Subjects' ADLs are studied with intervention compared to baseline (without intervention).

Device: A novel digital health device

Interventions

A videogame-generated virtual world designed for the AD/ADRD care dyad.

Also known as: DevaWorld
Persons residing in long-term care homes

Eligibility Criteria

AgeUp to 110 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • The subject will have a diagnosis of AD/ADRD, or symptoms of an undiagnosed AD/ADRD as observed by professional care staff and confirmed by the head of clinical care. The investigators will neither include nor exclude participation based on cognitive test scores. The subject will have had challenge(s) completing one or more ADLs in the previous month, as discussed at staff meetings, referenced in care plans, or observed/experienced by direct care staff.
  • Other specifications:
  • Understand English or Russian.
  • Can sit comfortably for at least 15 minutes in a chair/wheelchair at a table or propped up in bed or princess chair with a tray table
  • Are not known to be in pain
  • Have good vision, or good corrected vision (i.e., glasses)
  • Have good hearing, or good corrected hearing (i.e., aids)
  • May sometimes have anxiety or agitation when undertaking ADLs.

You may not qualify if:

  • Ineligible subjects are those with significant non-AD/ADRD neurological, psychiatric, or physical impairment or those who are totally dependent upon others for ADLs.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Bruceville Point Senior Living Community

Elk Grove, California, 95757, United States

Location

Elder Ashram

Oakland, California, 94602, United States

Location

Related Publications (3)

  • Quail Z, Bolton L, Massey K. Digital delivery of non-pharmacological intervention programmes for people living with dementia during the COVID-19 pandemic. BMJ Case Rep. 2021 Jun 17;14(6):e242550. doi: 10.1136/bcr-2021-242550.

    PMID: 34140328BACKGROUND
  • Kahle-Wrobleski K, Coley N, Lepage B, Cantet C, Vellas B, Andrieu S; Plasa DSA Group. Understanding the complexities of functional ability in Alzheimer's disease: more than just basic and instrumental factors. Curr Alzheimer Res. 2014 May;11(4):357-66. doi: 10.2174/1567205011666140317101419.

    PMID: 24635843BACKGROUND
  • Bourgeois J, Laye M, Lemaire J, Leone E, Deudon A, Darmon N, Giaume C, Lafont V, Brinck-Jensen S, Dechamps A, Konig A, Robert P. Relearning of Activities of Daily Living: A Comparison of the Effectiveness of Three Learning Methods in Patients with Dementia of the Alzheimer Type. J Nutr Health Aging. 2016 Jan;20(1):48-55. doi: 10.1007/s12603-016-0675-4.

    PMID: 26728933BACKGROUND

Related Links

MeSH Terms

Conditions

DementiaAlzheimer DiseaseNeurodegenerative DiseasesBehavior

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental DisordersTauopathies

Limitations and Caveats

Length of study reduced from 8 to 6 weeks due to staff participants' lack of adherence. Reasons: roster changes and absenteeism.

Results Point of Contact

Title
Dr Mandy Salomon
Organization
Mentia

Study Officials

  • Mandy Salomon, PhD

    Mentia DTx

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Model Details: A Virtual Game Environment as a Behavioral Intervention for Alzheimer Disease
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Chief Scientific Officer

Study Record Dates

First Submitted

May 31, 2022

First Posted

June 14, 2022

Study Start

June 9, 2022

Primary Completion

August 30, 2023

Study Completion

October 30, 2023

Last Updated

February 10, 2025

Results First Posted

February 10, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations